StockData
Eledon Pharmaceuticals, Inc. logo

Eledon Pharmaceuticals, Inc. (ELDN) income statement

ELDNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$1.78−0.12 (-6.32%)

Close on Nov 20, 2026Market cap $144.65MP/E –Yield –

Eledon Pharmaceuticals, Inc. financial ratios

See a number that looks wrong?